EUVIMEDEUVIMED entdecken
Crossref

Primary Large B-Cell Lymphomas of Immune-Privileged Sites With IRF4 Rearrangement: Clinicopathological and Molecular Characterization

Yuxiu Zhang, Anqi Li, Yimin Li, Lei Zhang, Lili Zhang, Lei Li, Yufeng Huang, Linlin Du, Jie Huang, Lei Dong, Haimin Xu, Binshen Ouyang und 3 weitere

Modern Pathology · 2026-11 · 39 (11) · 101084

DOI: 10.1016/j.modpat.2026.101084 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Modern Pathology, 2026-11. Verfasst von Yuxiu Zhang und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Zhongshan Hospital, Fudan University, Shanghai, China. Hauptthemen laut MEDLINE: Interferon Regulatory Factors, Gene Rearrangement, Lymphoma, Large B-Cell, Diffuse, Biomarkers, Tumor. Die Arbeit nennt 62 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Shanghai Municipal Health Commission, Science and Technology Commission of Shanghai Municipality.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Interferon Regulatory FactorsGene RearrangementLymphoma, Large B-Cell, DiffuseBiomarkers, TumorHumansInterferon Regulatory Factor-4MaleAdultAgedFemaleMiddle AgedIn Situ Hybridization, Fluorescence

Stichwörter der Autor:innen

IRF4 rearrangementlarge B-cell lymphomanext-generation sequencingprimary immune-privileged sites

Substanzen

Interferon Regulatory Factor-4Interferon Regulatory FactorsBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Pathology, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Department of Pathology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Department of Pathology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. Electronic address: yidoctor@163.com.
  • Department of Pathology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. Electronic address: wangchaofu@126.com.
  • Department of Pathology, Zhongshan Hospital, Fudan University, Shanghai, China. Electronic address: hou.yingyong@zs-hospital.sh.cn.

Förderung

  • National Natural Science Foundation of China
  • Shanghai Municipal Health Commission
  • Science and Technology Commission of Shanghai Municipality

Zitieren

APA

Zhang, Y., Li, A., Li, Y., Zhang, L., Zhang, L., Li, L., Huang, Y., Du, L., Huang, J., Dong, L., Xu, H., Ouyang, B., Yi, H., Wang, C., & Hou, Y. (2026). Primary Large B-Cell Lymphomas of Immune-Privileged Sites With IRF4 Rearrangement: Clinicopathological and Molecular Characterization. Modern Pathology, 39(11), 101084. https://doi.org/10.1016/j.modpat.2026.101084

Vancouver

Zhang Y, Li A, Li Y, Zhang L, Zhang L, Li L, et al. Primary Large B-Cell Lymphomas of Immune-Privileged Sites With IRF4 Rearrangement: Clinicopathological and Molecular Characterization. Modern Pathology. 2026;39(11):101084. doi:10.1016/j.modpat.2026.101084

BibTeX
@article{Zhang2026,
  author = {Zhang, Yuxiu and Li, Anqi and Li, Yimin and Zhang, Lei and Zhang, Lili and Li, Lei and Huang, Yufeng and Du, Linlin and Huang, Jie and Dong, Lei and Xu, Haimin and Ouyang, Binshen and Yi, Hongmei and Wang, Chaofu and Hou, Yingyong},
  title = {Primary Large B-Cell Lymphomas of Immune-Privileged Sites With IRF4 Rearrangement: Clinicopathological and Molecular Characterization},
  journal = {Modern Pathology},
  year = {2026},
  volume = {39},
  number = {11},
  pages = {101084},
  doi = {10.1016/j.modpat.2026.101084}
}
Kostenlos starten →